Background: Protein kinase B (PKB), and the p70 and p90 ribosomal S6 kinases (p70 S6 kinase and p90 Rsk, respectively), are activated by phosphorylation of two residues, one in the 'T-loop' of the kinase domain and, the other, in the hydrophobic motif carboxy terminal to the kinase domain. The 3-phosphoinositide-dependent protein kinase 1 (PDK1) activates many AGC kinases in vitro by phosphorylating the T-loop residue, but whether PDK1 also phosphorylates the hydrophobic motif and whether all other AGC kinases are substrates for PDK1 is unknown.
Background
Members of the AGC family of protein kinases, including protein kinase B (PKB) [1] [2] [3] , p70 ribosomal S6 kinase (p70 S6 kinase) [4, 5] , p90 ribosomal S6 kinase (Rsk) [6] , protein kinase C (PKC) isoforms [7] and cyclic AMP (cAMP)-dependent protein kinase (PKA) [8] , mediate many of the cellular effects of extracellular agonists by phosphorylating key regulatory proteins. Recent work has led to a greater understanding of how these protein kinases are activated in cells. For example, PKB is turned on following the agonist-induced activation of phosphoinositide 3-kinase (PI 3-kinase). This generates the second messenger phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ), leading to the recruitment of PKB to the plasma membrane where it becomes activated by phosphorylation of the Thr308 and Ser473 residues [9] . Thr308 lies in the 'T-loop' of the kinase domain, whereas Ser473 is located carboxy terminal to the catalytic domain, in a region termed the 'hydrophobic motif'. PKC isoforms [10] , p70 S6 kinase [11] , p90 Rsk [6, 12] and the serum-and glucocorticoid-regulated protein kinase (SGK) [13, 14] also possess residues, equivalent to Thr308 and Ser473 of PKB, whose phosphorylation is required for activation and/or stabilisation of these kinases in vivo.
The 3-phosphoinositide-dependent protein kinase 1 (PDK1) is thought to play a central role in activating AGC kinases (reviewed in [1, 15, 16] ). PDK1 phosphorylates the T-loop residue of PKB [15] [16] [17] [18] [19] [20] , p70 S6 kinase [21, 22] , p90 Rsk [23, 24] , SGK [13, 14] , conventional and novel PKC isoforms [25, 26] , atypical PKC isoforms [26] [27] [28] and related PKC isoforms [29, 30] either in vitro, or when overexpressed in cells. PKA is also phosphorylated by PDK1 in vitro at the equivalent residue (Thr197) and this phosphorylation is required for PKA activity [31] . Other AGC kinases, including the mitogen-and stress-activated protein kinase-1 (MSK1) [32] and the AMP-activated protein kinase (AMPK) [33] , also possess a potential PDK1 motif at the equivalent T-loop residue, but whether these kinases are substrates for PDK1 is not known.
PDK1 does not phosphorylate PKB significantly at Ser473, either in vitro or in cotransfection experiments, which initially suggested that a distinct protein kinase catalysed this reaction [17, 19] . More recently, however, the kinase domain of PDK1 was found to bind the carboxy-terminal 77 residues of PKC-related kinase-2 (PRK2), termed the PDK1-interacting fragment (PIF). In the presence of PIF, PDK1 and PtdIns(3,4,5)P 3 PKB was phosphorylated at both Thr308 and Ser473 [34] . In contrast, PDK1 phosphorylates the hydrophobic motif of p70 S6 kinase in the absence of the PIF, albeit to a very low stoichiometry, and interaction with the PIF prevents PDK1 from phosphorylating p70 S6 kinase at this residue in vitro, as well as at the T-loop threonine [35] . Moreover, in cells stimulated with the insulin-like growth factor 1 (IGF1), overexpression of the PIF, or a catalytically inactive mutant of PDK1, suppresses the phosphorylation of p70 S6 kinase at both residues, suggesting that PDK1 activity is required for the phosphorylation of the hydrophobic motif in vivo.
To gain further insights into the roles of PDK1 in cells, we generated mouse embryonic stem (ES) cells in which both copies of the PDK1 gene were disrupted. We found that, although these cells were viable, PKB and p70 S6 kinase were not activated by IGF1-stimulation, and p90 Rsk was not switched on following stimulation with tetradecanoylphorbol 13-acetate (TPA). In contrast, PKA, MSK1 and the AMPK were active, indicating that PDK1 is not rate limiting for the phosphorylation and activation of these enzymes in ES cells. Our results also indicate that ES cells contain a protein kinase, distinct from PDK1, which phosphorylates PKB at its hydrophobic motif.
Results

Generation of mouse ES cells lacking PDK1
We generated ES cells in which both copies of the PDK1 gene were disrupted by removal of exons 3 and 4, which encode the amino-terminal part of the kinase domain (PDK1 -/-cells; see the Materials and methods). The resulting frame-shift mutation prevents expression of the rest of the protein. We also generated ES cells in which the PDK1 gene was not disrupted but exons 3 and 4 were flanked by loxP sites (PDK1 +/+ cells). PDK1 -/-cells were viable and proliferated at a similar rate to PDK1 +/+ cells (data not shown). A genomic Southern blot analysis showed that both copies of the PDK1 gene had been disrupted in the PDK1 -/-cells ( Figure 1a ). Western blotting of lysates derived from these cells using two different PDK1 antibodies confirmed the absence of PDK1 protein in the PDK1 -/-cells (Figure 1b) . Furthermore, no PDK1 activity was detectable following immunoprecipitation of PDK1 from PDK1 -/-cell lysates, whereas PDK1 activity was readily detected in immunoprecipitates derived from PDK1 +/+ cells (Figure 1c) . Following chromatography of PDK1 -/-and PDK1 +/+ cell extracts on cation-exchange (MonoQ) and anion-exchange (MonoS) columns, we assayed for kinase activity capable of phosphorylating PKB at Thr308 in the presence of lipid vesicles containing PtdIns(3,4,5)P 3 [17] . No activity was detected in lysates derived from PDK1 -/-cells, although PDK1-like activity was readily detected in PDK1 +/+ lysates (data not shown).
PKB is phosphorylated at Ser473 but not Thr308 in PDK1 -/-cells PDK1 +/+ and PDK1 -/-ES cells were serum starved for 3 hours, then stimulated with IGF1, and PKBα immunoprecipitated from the cell lysates and assayed. IGF1 induced a robust stimulation of PKBα activity in the PDK1 +/+ cells within 1-2 minutes, which was sustained for up to 45 minutes. The addition of wortmannin for 10 minutes before stimulation with IGF1 reduced PKBα activity to undetectable levels in control cells and prevented its activation by IGF1 (Figure 2a ). In contrast, no PKBα activity was detected in PDK1 -/-cells following IGF1 stimulation (Figure 2a , right panel), despite PKBα being expressed at a level similar to that in PDK1 +/+ cells ( Figure 2b , lower panel). IGF1 also induced a fivefold activation of PKBγ in PDK1 +/+ cells, which attained a specific activity around fivefold lower than that of PKBα (0.5 U/mg). No detectable PKBγ activity was present in unstimulated or IGF1-stimulated PDK1 -/-cells (data not shown). No PKBβ protein was detected in lysates of ES cells and, consistent with this observation, no PKBβ activity was observed either in the PDK1 +/+ or PDK1 -/-cells following IGF1 stimulation (data not shown).
Phosphorylation of PKB at Thr308 and Ser473 was measured by immunoblotting cell lysates with antibodies that recognise PKB phosphorylated specifically at Thr308 or Ser473. In unstimulated PDK1 +/+ cells, PKB was phosphorylated to a very low level at Thr308 and Ser473. IGF1 induced a significant increase in the phosphorylation of both residues, which was completely inhibited by preincubation of the cells with wortmannin ( Figure 2b , upper and middle panels). In unstimulated PDK1 -/-cells, Thr308 was not phosphorylated and IGF1 failed to induce a detectable phosphorylation of PKB at Thr308 (Figure 2b , upper panel). In contrast, Ser473 was consistently phosphorylated to a greater extent in the unstimulated PDK1 -/-cells compared with PDK1 +/+ cells, and this increased 2-3-fold after IGF1 stimulation. Preincubation of the cells with wortmannin virtually abolished Ser473 phosphorylation in either unstimulated or IGF1-stimulated PDK1 -/-cells (Figure 2b , middle panel). To ensure that the antibodies were recognising PKB and not a closely related protein, PKBα was immunoprecipitated from cell lysates derived from control and IGF1-stimulated cells, and the immunoprecipitates again immunoblotted with the phosphorylation-specific Thr308 and Ser473 antibodies. These experiments confirmed that IGF1 stimulation of PDK1 -/-cells induced phosphorylation of PKBα only at Ser473 and not Thr308 (data not shown). The Ser473 antibodies also recognised PKBγ that was phosphorylated at its hydrophobic motif, and IGF1 stimulation of PDK1 -/-cells induced phosphorylation of immunoprecipitated PKBγ at its hydrophobic motif (data not shown). The phosphorylation-specific Thr308 antibodies did not appear to recognise PKBγ phosphorylated at its T-loop residue (data not shown).
Activation of PI 3-kinase in PDK1 -/-cells
PI 3-kinase activity associated with either the insulin receptor substrate-1 (IRS-1) (Figure 3a) or tyrosine-phosphorylated proteins (Figure 3b ) was also measured in the unstimulated and IGF1-treated PDK1 -/-and PDK1 +/+ cells. In unstimulated ES cells lacking PDK1, IRS1-associated PI 3-kinase activity was reproducibly twofold higher than that observed in PDK1 +/+ cells, and stimulation of both cells with IGF1 induced a 2-6-fold increase in PI 3-kinase activity (Figure 3a,b) . This may account for the higher basal level of phosphorylation of PKB at Ser473 in the PDK1 -/-cells (see discussion).
GSK3α α is not phosphorylated at Ser21 in PDK1 -/-cells
Glycogen synthase kinase-3 (GSK3) has multiple roles in cell regulation and is one of the best characterised cellular substrates of PKB (reviewed in [36] ). PKB phosphorylates GSK3α at Ser21, causing inactivation of this enzyme. Phosphorylation of GSK3α at Ser21 in ES cells was assessed by immunoblotting cell lysates with an antibody that recognises the Ser21-phosphorylated form of GSK3α In unstimulated PDK1 +/+ cells, GSK3α was significantly phosphorylated on Ser21, and phosphorylation at this residue was increased twofold following stimulation with IGF1 for 5 minutes. As expected, wortmannin significantly inhibited phosphorylation of GSK3α in IGF1-stimulated PDK1 +/+ cells (Figure 3c , upper panel). GSK3α was expressed at similar levels in PDK1 -/-and PDK1 +/+ cells (Figure 3c , lower panel), but GSK3α phosphorylation at Ser21 was undetectable in unstimulated or IGF1-stimulated PDK1 -/-cells (Figure 3a, upper panel) . cells were lysed, and 20 µg cell lysate protein was electrophoresed on a 10% SDS-polyacrylamide gel and immunoblotted with antibodies raised against either the entire PDK1 protein (antibody 1) or just the carboxy-terminal portion (antibody 2). PDK1 in the PDK1 +/+ cells comigrates with a bovine serum albumin (67 kDa) marker and is absent in the PDK1 -/-cells. (c) As in (b) except that PDK1 was immunoprecipitated from 100 µg cell lysate protein with either PDK1 antibody 1 or 2, and PDK1 was assayed with PDKtide as substrate as described previously [47] . The data are presented as the mean ± SEM for two separate experiments, with each determination carried out in triplicate.
Figure 2
PKB is not activated in PDK1 -/-cells. (a) PDK1 +/+ and PDK1 -/-ES cells were serum-starved for 3 h, then incubated for 10 min with or without 100 nM wortmannin. The cells were either left unstimulated or stimulated with 100 ng/ml IGF1 for the times indicated in the continued presence or absence of wortmannin. The cells were lysed, and PKBα was immunoprecipitated from the lysates and assayed. The data are presented as the mean ± SEM of two separate experiments, with each determination carried out in triplicate. (b) As in (a) except that 20 µg cell lysate protein was electrophoresed on a 10% SDS-polyacrylamide gel and immunoblotted with antibodies that recognise the PKBα protein (PKBα total) or PKB phosphorylated either at Thr308 (T308-P) or at Ser473 (S473-P).
protein S6 [5] , enabling the efficient translation of mRNA molecules containing a polypyrimidine tract at their 5′ transcriptional start site [37] . In unstimulated PDK1 +/+ cells, the p70 S6 kinase was significantly active and its activity was increased twofold following stimulation with IGF1 for 45 minutes (the time at which p70 S6 kinase is maximally activated, data not shown). As expected, rapamycin reduced p70 S6 kinase activity to undetectable levels ( Figure 4 ). The p70 S6 kinase was expressed at similar levels in the PDK1 -/-and PDK1 +/+ cells ( Figure 4 , lower panel), but p70 S6 kinase activity was undetectable in unstimulated or IGF1-stimulated PDK1 -/-cells ( Figure 4) . Phosphorylation of the p70 S6 kinase at Thr389 in the hydrophobic motif was measured with a phosphorylationspecific antibody. In unstimulated PDK1 +/+ cells, p70 S6 kinase was significantly phosphorylated at Thr389, and this was increased twofold by IGF1 stimulation, consistent with the effect of IGF1 on activity. In contrast, rapamycin induced the complete dephosphorylation of Thr389. No phosphorylation of p70 S6 kinase at Thr389 was detected in unstimulated or IGF1-stimulated PDK1 -/-cells. We have been unable to determine whether p70 S6 kinase is phosphorylated at its T-loop residue in PDK1 -/-cells as the phosphorylation-specific antibodies that we have raised against this epitope are not sensitive enough to detect the phosphorylation of endogenous p70 S6 kinase at this residue in a cell lysate (data not shown).
The p90 Rsk is not activated by TPA in PDK1 -/-cells
The p90 Rsk is a well-established substrate for the mitogen-activated protein kinase (MAP kinase) family members ERK1 and ERK2 [6] . Stimulation of PDK1 +/+ cells with TPA resulted in a sixfold activation of p90 Rsk (Figure 5a ), measured after its immunoprecipitation from cell lysates with an antibody that recognises all p90 Rsk isoforms. As expected, activation of p90 Rsk was largely prevented by preincubation of the cells with PD 98059, an inhibitor of the activation of MAP kinase kinase-1 (data not shown). In contrast, p90 Rsk activity was virtually undetectable in PDK1 -/-cells and TPA stimulation failed to induce activity, despite p90 Rsk being expressed at similar levels in PDK1 -/-and PDK1 +/+ cells (Figure 5a , lower panel). These results were confirmed using p90 Rsk isoform-specific antibodies. These experiments detected significant levels of Rsk1, Rsk2 and Rsk3 activity in unstimulated PDK1 +/+ cell lysates, each of which were activated approximately threefold by TPA. No detectable Rsk1, Rsk2 or Rsk 3 activity was observed in either unstimulated or TPAstimulated PDK1 -/-cells despite the expression of each isoform at similar levels in PDK1 -/-and PDK1 +/+ cells (data not shown). Phosphorylation of GSK3α at Ser21, and PI 3-kinase activity in PDK1 -/-cells. (a,b) ES cells were serum-starved for 3 h, then left unstimulated, or stimulated with either 100 ng/ml IGF1 or 200 ng/ml TPA for 10 min. The cells were lysed and PI 3-kinase was immunoprecipitated (IP) from the same lysate with either (a) anti-IRS-1 antibodies or (b) antiphosphotyrosine antibodies and then assayed as described in the Supplementary material. (c) The cells were stimulated, then lysed and 20 µg cell lysate protein electrophoresed on a 10% SDS-polyacrylamide gel and immunoblotted with antibodies that recognise either GSK3α phosphorylated at Ser21 (S21-P) or all GSK3α protein (GSK3α total). Similar results were obtained in three separate experiments and the data are presented as the mean ± SEM for three separate experiments, with each determination carried out in triplicate (in the case of panels a,b).
Figure 4
The p70 S6 kinase is not activated or phosphorylated at its hydrophobic motif in PDK1 -/-cells. PDK1 +/+ and PDK1 -/-ES cells were serum-starved for 3 h, then incubated for 10 min with or without 100 nM rapamycin. The cells were either left unstimulated or stimulated with 100 ng/ml IGF1 for 45 min in the continued presence or absence of rapamycin. The cells were lysed and p70 S6 kinase was immunoprecipitated from the same lysate and assayed. The data are presented as the mean ± SEM for three separate experiments, with each determination carried out in triplicate. Cell lysate protein (20 µg) was electrophoresed on a 10% SDS-polyacrylamide gel and immunoblotted with antibodies that recognise either all p70 S6 kinase or just the Thr389-phosphorylated form (T389-P).
TPA stimulation induced an upward shift in the electrophoretic mobility of p90 Rsk in PDK1 -/-cells to the same extent as that observed in the PDK1 +/+ cells (Figure 5a , lower panel), suggesting that ERK1/ERK2 were phosphorylating p90 Rsk in the PDK1 -/-cells. This indicates that p90 Rsk fails to become activated in the PDK1 -/-cells because it is not phosphorylated at the site targeted by PDK1. To investigate this further, we incubated p90 Rsk immunoprecipitates (derived from unstimulated and TPAstimulated cells), with PDK1 and Mg-ATP before assay. We found that p90 Rsk, derived from either unstimulated PDK1 +/+ or PDK1 -/-cells, or from TPA-stimulated PDK1 +/+ cells, was not activated significantly by incubation with Mg-ATP and PDK1 ( Figure 5, compare panels a,b) . Nevertheless, p90 Rsk derived from TPA-stimulated PDK1 -/-cells was partially re-activated following incubation with PDK1 and Mg-ATP (Figure 5b ).
There is evidence that p90 Rsk phosphorylates GSK3α at Ser21 when cells are stimulated with phorbol esters (which do not induce PKB activation) and other growth factors [38, 39] . In the present study, stimulation of PDK1 +/+ cells with TPA induced a significant increase in GSK3α phosphorylation at Ser21 (Figure 3c ) which, in contrast to the IGF1-induced phosphorylation of GSK3α at Ser21, was not prevented by prior incubation of the cells with the PI 3-kinase inhibitor LY 294002 (data not shown). Consistent with the lack of p90 Rsk activity in PDK1 -/-cells, no phosphorylation of GSK3α at this residue was detected in TPA-stimulated PDK1 -/-cells (Figure 3c ). ERK1/ERK2 were activated by TPA to a similar extent in the PDK1 -/-cells and PDK1 +/+ cells, indicating that the lack of p90 Rsk activation in the PDK1 -/-cells is not due to deficient MAP kinase activation. Interestingly, however, the basal activity of ERK1/ERK2 was significantly higher in the PDK1 -/-cells compared with the PDK1 +/+ cells (Figure 5c ). Furthermore, pre-incubation of cells with LY 294002 (100 µM) for 1 hour (Figure 5c ) did not reduce (and even slightly increased) ERK1/ERK2 activity in unstimulated or TPA-stimulated PDK1 -/-cells or PDK1 +/+ cells, indicating that the elevated PI 3-kinase activity in the PDK1 -/-cells ( Figure 3) was not responsible for the increased basal ERK1/2 in these cells (Figure 5c ). Furthermore, LY 294002 had no significant effect on the TPA-induced activation of p90 Rsk in the PDK1 +/+ cells (data not shown). p38 MAP kinase [32] . The amino-acid sequences surrounding the T-loop motif of p90 Rsk isoforms and MSK1 are identical, suggesting that MSK1 should also be a substrate for PDK1. Stimulation of the PDK1 +/+ cells with TPA or exposure to ultraviolet (UV) radiation, induced a large activation of MSK1 (Figure 6a ). As expected, the activation of MSK1 by TPA was largely prevented by preincubating the cells with PD 98059, while the UV-induced activation was prevented by pretreatment with SB 203580, an inhibitor of p38 MAP kinase (data not shown). Surprisingly, however, MSK1 was activated by TPA and by UV radiation to a similar extent in the PDK1 -/-and PDK1 +/+ cells (Figure 6a ).
PKA is active in the PDK1 -/-cells
PKA activity was measured in cell lysates derived from the PDK1 +/+ and PDK1 -/-cells. In both cell lysates, the specific activity of PKA was found to be similar, and activity was stimulated by the addition of cAMP. In contrast, addition of the PKA inhibitor peptide, PKI, to the assays, a specific peptide inhibitor of PKA, strongly suppressed activity (Figure 7a ). To confirm this result, we measured PKA activity following its immunoprecipitation from PDK1 -/-and PDK1 +/+ cell lysates using a specific antibody. This assay confirmed that the specific activities of PKA were similar in the PDK1 -/-and PDK1 +/+ cells (data not shown). Western blotting of the ES cell lysates indicated the presence of two closely migrating PKA isoforms that were expressed at similar levels in both the PDK1 -/-and PDK1 +/+ cells (Figure 7b ).
We generated antibodies that only recognise Thr197-phosphorylated PKA, the site of PDK1 phosphorylation. These antibodies recognised active PKA purified from ) or an antibody that recognises Thr197-phosphorylated PKA (P-Thr197 antibody). The P-Thr197 immunoblots were also incubated with either the phosphorylated or unphosphorylated Thr197 peptide immunogen used to raise the antibody. PKA affinity purified from distinct ES cell lysates in two separate experiments was electrophoresed in parallel. PKA purified from bovine heart (1 µg) was used as a control. The PKA isoform that interacts with PKI-Sepharose resin corresponds to the lower molecular weight species observed in the immunoblot shown in (b).
bovine heart and their specificity for Thr197-phosphorylated PKA was established by the fact that recognition was abolished by preincubating the antibody with the phosphopeptide immunogen used to raise the antibody, whereas the dephosphorylated form of this peptide had no effect (Figure 7c ). As this antibody was not sufficiently sensitive to detect phosphorylated PKA in ES cell extracts (data not shown), we affinity purified PKA from a cell lysate using PKI covalently coupled to Sepharose (see Supplementary material) before immunoblotting with the phosphorylation-specific Thr197 antibody. Using this procedure, we found that PKA extracted from either the PDK1 -/-cells or PDK1 +/+ cells was similarly phosphorylated at Thr197 (Figure 7c ).
AMPK is active in the PDK1 -/-cells
AMPK is an AGC kinase that is activated by depletion of ATP, which then inhibits ATP-consuming anabolic pathways [40] . AMPK was assayed in PDK1 -/-and PDK1 +/+ cells following immunoprecipitation from the cell lysates with specific antibodies raised against the α1 isoform. AMPK displayed similar activity in cell lysates derived from unstimulated PDK1 -/-or PDK1 +/+ cells, being activated twofold by the addition of AMP (Figure 8 ). Exposure of these cells to sodium arsenite, which depletes ATP and activates AMPK [41] by triggering its phosphorylation, did not increase its activity further (data not shown).
Thus, AMPK appears to be highly active even in the unstimulated ES cells. Western blotting of the ES cell lysates indicated that the α1 isoform was expressed at similar levels in both the PDK1 -/-and PDK1 +/+ cells (Figure 7b ). The α2 isoform of AMPK also displayed similar activity in cell lysates derived from unstimulated PDK1 -/-or PDK1 +/+ cells (data not shown).
Discussion
We found that mouse ES cells lacking PDK1 are viable and proliferate at a similar rate to control ES cells expressing PDK1. This finding is somewhat surprising as disruption of the genes encoding PDK1 homologues in budding yeast [42, 43] or fission yeast [44] result in a lethal phenotype in all growth conditions tested, suggesting that activation of one or more AGC kinases is essential for cell survival and/or proliferation in yeast. The viability of PDK1 -/-ES cells is useful as it enables us to test the role of PDK1 in regulating AGC kinases in mammalian cells.
IGF1 activated PI 3-kinase in cells lacking PDK1 (Figure 3 ), but did not induce activation of PKB or phosphorylation of PKB at Thr308 (Figure 2) . Consistent with this finding, GSK3α, a well-characterised intracellular substrate for PKB, was not phosphorylated at the site of PKB phosphorylation in unstimulated or IGF1-stimulated PDK1 -/-cells (Figure 3c ). This establishes that, in mammalian cells, PDK1 does indeed mediate the phosphorylation of PKB at Thr308, leading to its activation, and provides further evidence that GSK3 is phosphorylated by PKB in cells.
Significantly, PKB was phosphorylated at Ser473, even in unstimulated PDK1 -/-cells, and this was increased about twofold following stimulation with IGF1. Preincubation of cells with wortmannin reduced the level of Ser473 phosphorylation to below basal levels in both unstimulated and IGF1-treated PDK1 -/-cells (Figure 2) . Thus, ES cells lacking PDK1 contain a kinase distinct from PDK1, termed PDK2, which is capable of phosphorylating PKB at Ser473, and whose activity towards PKB is dependent on PI 3-kinase. In our previous studies, we found that PDK1 was capable of phosphorylating PKB at Ser473 as well as Thr308 in the presence of the carboxy-terminal fragment of PRK2 (PIF; see Background). We also found that the major endogenous activity in brain cytosol that phosphorylated Ser473 of PKB in a PtdIns (3,4,5)P 3 -dependent manner was immunoprecipitated with a PDK1 antibody. In view of these findings, it is unclear whether this activity comprises PDK1 complexed to a 'PIF-like' protein and/or PDK1 complexed to a distinct PDK2. A recent study by Toker and Newton [45] suggests that following phosphorylation of PKB at Thr308, PKB autophosphorylates itself at Ser473. The finding in this paper that Ser473 of PKB is phosphorylated in PDK1 -/-ES cells in the absence of Thr308 phosphorylation (Figure 2 ) argues against this possibility. AMPK is activated in PDK1 -/-cells. PDK1 +/+ and PDK1 -/-ES cells were lysed and the α1 isoform of AMPK assayed after its immunoprecipitation from the cell lysates in the presence or absence of 100 µM AMP. The error bars represent the average ± SEM for two separate experiments, with each determination carried out in triplicate. Cell lysate protein (20 µg) was electrophoresed on a 10% SDS-polyacrylamide gel and immunoblotted with an antibody that recognises the α1 isoform of AMPK.
The higher level of Ser473 kinase activity in cells lacking PDK1 may result from the twofold higher level of PI 3-kinase activity observed in these cells compared with PDK1 +/+ cells (Figure 3 ). This result suggests that PDK1, PKB, another PDK1-activated AGC kinase, or one of their substrates, triggers a negative feedback pathway that reduces PI 3-kinase activity and/or PDK2 activity in unstimulated cells. Consistent with this model, Roth and colleagues have shown that PKB phosphorylates IRS-1 in vitro and that this may inhibit its ability to activate PI 3-kinase [46] .
In unstimulated PDK1 +/+ cells, p70 S6 kinase was partially active and phosphorylated at Thr389 in its hydrophobic motif and its activity increased twofold in response to IGF1. Strikingly, however, p70 S6 kinase was completely inactive and not detectably phosphorylated at Thr389 in PDK1 -/-cells ( Figure 4 ). These findings are consistent with our previous observations that PIF inhibits the PDK1-catalysed phosphorylation of Thr389 in vitro, and prevents the phosphorylation of p70 S6 kinase at its T-loop residue and hydrophobic motif in cotransfection experiments [35] . These observations do not resolve the issue of whether PDK1 (perhaps bound to a regulatory protein) directly phosphorylates p70 S6 kinase at its hydrophobic motif, or whether PDK1 activates (or regulates the expression of) a distinct protein kinase that phosphorylates p70 S6 kinase at the hydrophobic motif.
We have recently identified a hydrophobic pocket on the kinase domain of PDK1 with which PIF interacts [47] . Our experiments indicate that this PIF-binding pocket enables PDK1 to interact with many of its substrates including p70 S6 kinase and atypical PKC isoforms but not PKB. PDK1 is unable to interact with or phosphorylate p70 S6 kinase in the presence of PIF [35] and this is also true for SGK (T. Kobayashi and P.C., unpublished work) and for PKCζ and PRK2 (A.B., R. Biondi and D.R.A., unpublished data). These observations suggest that PDK1 substrates such as p70 S6 kinase, PKCζ and PRK2 interact with PDK1 at a site that overlaps with the PIF-binding site, before they are phosphorylated by PDK1. In contrast, this is not the case for PKB as the phosphorylation of PKB by PDK1 is not inhibited in the presence of PIF either in vitro or in 293 cells transfected with PIF and stimulated with IGF1 [35] . As PKB and PDK1 both interact with 3-phosphoinositides through their pleckstrin homology (PH) domains, it is possible that this lipid second messenger, and not a specific docking site, is an important determinant for colocalising these molecules at the plasma membrane, hence allowing PDK1 to phosphorylate PKB [48] .
The p90 Rsk isoforms are unusual in that they contain two protein kinase domains within a single polypeptide. The role of the carboxy-terminal kinase domain is to activate the amino-terminal kinase domain, allowing the latter to phosphorylate exogenous substrates [6, 12] . The aminoterminal domain possesses the highest homology to AGC kinases, and a T-loop site (Ser222 in p90 Rsk1) and hydrophobic motif (Ser381 in p90 Rsk1) that are similar to those found in PKB and p70 S6 kinase. The phosphorylation of four residues (Ser222, Ser364, Ser381 and Thr574) is essential for activation of p90 Rsk1. ERK1/ERK2 phosphorylate Thr574 in the carboxy-terminal domain and Thr360 and Ser364 which are located between the aminoterminal and carboxy-terminal kinase domains. The phosphorylation of Thr574 activates the carboxy-terminal kinase domain, which then phosphorylates Ser381. PDK1 phosphorylates Ser222, activating p90 Rsk in vitro and in cotransfection experiments [23, 24] . Our finding that p90 Rsk is inactive in PDK1 -/-cells, and partially activatable by incubation with PDK1 and Mg-ATP ( Figure 5 ), provides strong evidence that p90 Rsk is indeed a substrate for PDK1 in vivo.
Previous studies have shown that p90 Rsk1 is highly phosphorylated at the T-loop residue, even in unstimulated cells, phosphorylation only increasing marginally in response to TPA [12] . Consistent with this finding, p90 Rsk from unstimulated Swiss 3T3 cells can be fully activated by incubation with ERK1/ERK2 and Mg-ATP in vitro [49] . Moreover, activation of p90 Rsk by TPA is prevented by inhibitors of the ERK1/ERK2 cascade, but not by inhibitors of PI 3-kinase in many cell types, including PDK1 +/+ ES cells (data not shown). These observations indicate that phosphorylation by PDK1 does not activate p90 Rsk per se, but rather permits activation after phosphorylation by ERK1/ERK2. Thus, unlike PKB and p70 S6 kinase, the PDK1 site in p90 Rsk is phosphorylated constitutively in unstimulated cells.
Interestingly, ERK1/ERK2 activity was consistently about twofold higher in unstimulated PDK1 -/-cells than in unstimulated PDK1 +/+ cells (Figure 5c ). This suggests that PDK1 participates in a negative feedback pathway to suppress the activation of ERK1/ERK2 in these cells. This is not mediated by the elevated PI 3-kinase activity observed in PDK1 -/-cells (Figure 3 ), because preincubation of the cells with LY 294002 for 1 hour did not reduce the elevated basal ERK1/ERK2 activity (Figure 5c ). It has been proposed that p90 Rsk phosphorylates and reduces the activity of mSOS, the GDP-GTP exchanger for Ras [50] . Therefore, mSOS may be more active in the PDK1 -/-cells, which lack p90 Rsk activity, resulting in higher levels of Ras-GTP and a higher level of ERK1/ERK2 activity. Alternatively, PKB activity in control PDK1 +/+ cells may suppress the basal level of ERK1/ERK2 activity by inhibiting Raf [51] , the protein kinase that lies downstream of Ras-GTP. If this pathway operates in ES cells, the PDK1 -/-cells that lack PKB activity would be expected to have elevated Raf activity and, hence, a higher ERK1/ERK2 activity.
All PKC isoforms are activated by phosphorylation of their T-loop residue, a reaction proposed to be mediated by PDK1 [10] . It will therefore be important, in future work, to establish whether PKC isoforms are active and phosphorylated in PDK1 -/-cells. Nevertheless, as TPA still stimulates the activation of the ERK pathway in PDK1 -/-cells to the same extent as in the PDK1 +/+ cells (Figure 5c ), one or more PKC isoforms may be phosphorylated at their T-loop residue in the PDK1 -/-cells. It should also be noted that there could be other kinases that are able to activate PKC isoforms or other AGC kinases in cells, perhaps in response to stimuli that we have not investigated. The activation of other AGC kinases by a 'PDK1-independent mechanism' or the normal activation of the ERK1/ERK2 pathway, could account for the viability of the PDK1 -/-cells.
The MSK isoforms (MSK1 and MSK2) are most closely related to p90 Rsk and, like p90 Rsk, also contain two protein kinase domains within a single polypeptide. All the in vivo phosphorylation sites in p90 Rsk and the residues surrounding them are conserved in MSK isoforms [32] . Moreover, the mutation of Thr212 to Ala, the residue equivalent to the PDK1 site of p90 Rsk1, completely inactivates MSK1 activity (J.S.C.A., unpublished observations). Surprisingly, however, MSK1 was similarly activated in PDK1 -/-and PDK1 +/+ cells ( Figure 6 ). Thus, PDK1 activity is not rate limiting for the phosphorylation of MSK1 at Thr212 in ES cells. Presumably, MSK1 is phosphorylated at this site by another kinase, or by MSK1 itself.
PDK1 phosphorylates PKA at its T-loop residue (Thr197) in vitro and phosphorylation of this residue is required for PKA activity [31] . Unlike other members of the AGC subfamily, however, PKA is also able to phosphorylate itself at this residue when expressed in bacteria, and thus it is uncertain whether PKA itself or PDK1 mediates the phosphorylation of Thr197 in cells. The present study indicates that PDK1 is not rate limiting for the phosphorylation of PKA at Thr197 in ES cells, as PKA is fully active in the PDK1 -/-cells and phosphorylated at Thr197 (Figure 7) . AMPK is activated in cells by the phosphorylation of a threonine residue in its T-loop, [33, 40] , but the kinase that mediates this phosphorylation has not yet been purified to homogeneity. We have been unable to activate AMPK in vitro by incubating it with PDK1 in the presence of Mg-ATP (D.R.A. and D.G. Hardie, unpublished observations). The finding that both mammalian AMPK isoforms are equally active in PDK1 -/-cells and PDK1 +/+ cells (Figure 8 ), provides further evidence that PDK1 does not mediate the activation of AMPK in cells.
The constitutive PI 3-kinase-independent phosphorylation of p90 Rsk at Ser222 in unstimulated cells indicates that this residue is phosphorylated by a form of PDK1 that is active in unstimulated cells. However, the form of PDK1 that activates PKB in vivo appears to be PtdIns(3,4,5)P 3 -dependent for the following reasons. First, the activation of PKB by PDK1 in vitro requires the binding of PtdIns(3,4,5)P 3 to PDK1 as well as PKB [48] . Second, insulin is still able to induce the activation of a PKB mutant that lacks a PH domain (and therefore cannot bind PtdIns(3,4,5)P 3 ) and this is prevented by inhibitors of PI 3-kinase [52] . When PDK1 is overexpressed in cells, a small but significant proportion associates with the plasma membrane while the remainder is cytosolic and excluded from the nucleus [48] . We therefore hypothesise that cells contain at least two forms of PDK1; a plasma membrane-associated form that is PI(3,4,5) P 3 -dependent and which activates PKB, and a cytosolic form that is constitutively active and which phosphorylates AGC family members such as p90 Rsk. As interaction with PIF converts PDK1 from a PtdIns(3,4,5)P 3 -independent form to a form that is activated by PtdIns(3,4,5)P 3 [34] , it is possible that the membrane-associated form of PDK1 comprises PDK1 complexed to a 'PIF-like' molecule. The interaction of PIF with PDK1 also converts it to a form that is capable of phosphorylating the hydrophobic motif as well as the T-loop site. However, although the membrane-associated form of PDK1 may be capable of phosphorylating the hydrophobic motif of PKB, the results presented here demonstrate the existence of at least one further protein kinase capable of phosphorylating this residue in vivo. The identification and characterisation of this protein kinase(s) remains a major challenge.
Supplementary material
A figure showing the mouse PDK1 gene structure and the knockout strategy used, and additional methodological detail, are available at http://current-biology.com/supmat/supmatin.htm.
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